Short bowel condition Withdrawn Phase 4 Trials for Exenatide (DB01276)

Also known as: Short-bowel syndrome / Short Bowel Syndrome / Congenital volvulus

IndicationStatusPhase
DBCOND0020575 (Short bowel condition)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01818648Exenatide on GI Motor Function and Permeability in Short Bowel SyndromeTreatment